Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2015-08-20 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于控股股东及实际控制人首次增持公司股份的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the increase in shareholding by the company's controlling shareholder and actual controller, Mr. Zhang Xuke. It details the number of shares purchased, the percentage of total shares held before and after the purchase, and the future plan to increase holdings. The document references compliance with securities laws and stock exchange rules related to shareholding increases. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds.
2015-08-20 Chinese
信息披露事务管理制度
Governance Information Classification · 95% confidence The document is titled as an "Information Disclosure Management System" for a company, detailing principles, procedures, and responsibilities related to information disclosure. It references various regulatory requirements and outlines the company's internal rules for disclosure of financial reports, major events, and other corporate information. It does not contain actual financial data, financial statements, or audit results. Instead, it is a governance document describing how the company manages and discloses information in compliance with laws and stock exchange rules. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2015-08-19 Chinese
第二届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司 (Pulike Bioengineering Co., Ltd.). It details the convening of the second board's tenth meeting, the attendance, and the voting results on various agenda items such as approval of the 2015 semi-annual report, fundraising usage, capital increase, and amendments to internal management systems. The document does not contain the actual semi-annual report or financial statements but refers to the Shanghai Stock Exchange website for details. It is a board meeting resolution announcement, not a full financial report or earnings release. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2015-08-19 Chinese
增加首次公开发行股票募集资金专用帐户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the addition of a new special account for funds raised from the company's initial public offering (IPO). It details the opening of a new dedicated account for managing IPO proceeds and compliance with regulatory requirements. The content focuses on capital management and the use of raised funds, without presenting financial statements or performance data. The document length is short (1090 characters) and it is clearly an announcement about capital/fund management rather than a full financial report or audit. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2015-08-19 Chinese
2015年半年报募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2015年半年报募集资金存放与实际使用情况的专项报告," which translates to a special report on the storage and actual use of raised funds for the 2015 half-year period. It details the amount of funds raised, their management, usage, and compliance with regulatory requirements. The document includes specific financial figures related to fundraising and usage but is focused solely on the use of raised capital rather than a full interim financial report. The length is 3330 characters, which is relatively short and focused on a specific topic. This type of document is a specialized report on fundraising usage, which aligns best with the category "Capital/Financing Update (CAP)" as it updates on the company's fundraising and capital usage activities. It is not a full interim report (IR) because it lacks comprehensive financial statements and broader financial analysis. It is not a regulatory filing (RNS) because it contains substantive financial data on fundraising usage. Therefore, the best classification is CAP with high confidence.
2015-08-19 Chinese
2015年半年度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled '2015 年半年度报告' which translates to '2015 Half-Year Report'. It contains detailed financial data, management discussion and analysis, accounting data, financial indicators, and operational performance for the first half of 2015. The document includes sections such as '董事会报告' (Board of Directors Report), financial data tables, and detailed narrative on business operations and financial results. The length is substantial (15,000 characters) and it contains actual financial statements and substantive financial data. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year, containing actual financial statements and analysis. It is not an announcement or a brief summary, nor is it a full annual report (10-K). Therefore, the correct classification is IR with high confidence. H1 2015
2015-08-19 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.